AXL expression + EGFR mutation

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

AXL expression + EGFR mutation	Non Small Cell Lung Cancer	AXL expression + EGFR mutation	Non Small Cell Lung Cancer	osimertinib Sensitive: C3 – Early Trials osimertinib Sensitive : C3	osimertinib Sensitive: C3 – Early Trials osimertinib Sensitive : C3
AXL expression + EGFR mutation	Non Small Cell Lung Cancer	AXL expression + EGFR mutation	Non Small Cell Lung Cancer	erlotinib + ramucirumab Resistant: D – Preclinical erlotinib + ramucirumab Resistant : D	erlotinib + ramucirumab Resistant: D – Preclinical erlotinib + ramucirumab Resistant : D

Associations